Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmela Paolillo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicineCarmela Paolillo, Eric Londin, Paolo Fortina
Clinical Chemistry|March 16, 2019
Single-Cell GenomicsCarmela Paolillo, Eric Londin, Paolo Fortina
International Journal of Molecular Sciences|April 17, 2025
The Significance of Fungal Specialized Metabolites in One Health PerspectivesPierluigi Reveglia, Carmela Paolillo, Gaetano Corso
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 9, 2014
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platformGiuseppe Albino, Francesca Vendittelli, Carmela Paolillo, et al.
Antibodies (Basel, Switzerland)|March 24, 2026
Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence PatternsMassimo Papale, Carmela Paolillo, Loredana Iafelice, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patientsFrancesca Vendittelli, Marco Raffaelli, Guido Fadda, et al.
Cancers|May 23, 2020
Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of RomeConcetta Santonocito, Roberta Rizza, Ida Paris, et al.
Archives of Pathology & Laboratory Medicine|June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic IsoformsRobyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
The International Journal of Biological Markers|December 9, 2017
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancerMara Fanelli, Alessia Camperchioli, Lella Petrella, et al.
The International Journal of Biological Markers|June 20, 2019
Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastasesFelice Giuliante, Elena Panettieri, Francesco Ardito, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicineCarmela Paolillo, Eric Londin, Paolo Fortina
Clinical Chemistry|March 16, 2019
Single-Cell GenomicsCarmela Paolillo, Eric Londin, Paolo Fortina
International Journal of Molecular Sciences|April 17, 2025
The Significance of Fungal Specialized Metabolites in One Health PerspectivesPierluigi Reveglia, Carmela Paolillo, Gaetano Corso
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 9, 2014
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platformGiuseppe Albino, Francesca Vendittelli, Carmela Paolillo, et al.
Antibodies (Basel, Switzerland)|March 24, 2026
Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence PatternsMassimo Papale, Carmela Paolillo, Loredana Iafelice, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2012
Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patientsFrancesca Vendittelli, Marco Raffaelli, Guido Fadda, et al.
Cancers|May 23, 2020
Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of RomeConcetta Santonocito, Roberta Rizza, Ida Paris, et al.
Archives of Pathology & Laboratory Medicine|June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic IsoformsRobyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
The International Journal of Biological Markers|December 9, 2017
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancerMara Fanelli, Alessia Camperchioli, Lella Petrella, et al.
The International Journal of Biological Markers|June 20, 2019
Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastasesFelice Giuliante, Elena Panettieri, Francesco Ardito, et al.
Pageof 3